Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15252564rdf:typepubmed:Citationlld:pubmed
pubmed-article:15252564lifeskim:mentionsumls-concept:C0456387lld:lifeskim
pubmed-article:15252564lifeskim:mentionsumls-concept:C0175921lld:lifeskim
pubmed-article:15252564lifeskim:mentionsumls-concept:C2347052lld:lifeskim
pubmed-article:15252564pubmed:issue11lld:pubmed
pubmed-article:15252564pubmed:dateCreated2004-7-14lld:pubmed
pubmed-article:15252564pubmed:abstractTextThree new Mn(III) porphyrin catalysts of O2.-dismutation (superoxide dismutase mimics), bearing ether oxygen atoms within their side chains, were synthesized and characterized: Mn(III) 5,10,15,20-tetrakis[N-(2-methoxyethyl)pyridinium-2-yl]porphyrin (MnTMOE-2-PyP(5+)), Mn(III)5,10,15,20-tetrakis[N-methyl-N'-(2-methoxyethyl)imidazolium-2-yl]porphyrin (MnTM,MOE-2-ImP(5+)) and Mn(III) 5,10,15,20-tetrakis[N,N'-di(2-methoxyethyl)imidazolium-2-yl]porphyrin (MnTDMOE-2-ImP(5+)). Their catalytic rate constants for O2.-dismutation (disproportionation) and the related metal-centered redox potentials vs. NHE are: log k(cat)= 8.04 (E(1/2)=+251 mV) for MnTMOE-2-PyP(5+), log k(cat)= 7.98 (E(1/2)=+356 mV) for MnTM,MOE-2-ImP(5+) and log k(cat)= 7.59 (E(1/2)=+365 mV) for MnTDMOE-2-ImP(5+). The new porphyrins were compared to the previously described SOD mimics Mn(III) 5,10,15,20-tetrakis(N-ethylpyridinium-2-yl)porphyrin (MnTE-2-PyP(5+)), Mn(III) 5,10,15,20-tetrakis(N-n-butylpyridinium-2-yl)porphyrin (MnTnBu-2-PyP(5+)) and Mn(III) 5,10,15,20-tetrakis(N,N'-diethylimidazolium-2-yl)porphyrin (MnTDE-2-ImP(5+)). MnTMOE-2-PyP(5+) has side chains of the same length and the same E(1/2), as MnTnBu-2-PyP(5+)(k(cat)= 7.25, E(1/2)=+ 254 mV), yet it is 6-fold more potent a catalyst of O2.-dismutation , presumably due to the presence of the ether oxygen. The log k(cat)vs. E(1/2) relationship for all Mn porphyrin-based SOD mimics thus far studied is discussed. None of the new compounds were toxic to Escherichia coli in the concentration range studied (up to 30 microM), and protected SOD-deficient E. coli in a concentration-dependent manner. At 3 microM levels, the MnTDMOE-2-ImP(5+), bearing an oxygen atom within each of the eight side chains, was the most effective and offered much higher protection than MnTE-2-PyP(5+), while MnTDE-2-ImP(5+) was of very low efficacy.lld:pubmed
pubmed-article:15252564pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15252564pubmed:languageenglld:pubmed
pubmed-article:15252564pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15252564pubmed:citationSubsetIMlld:pubmed
pubmed-article:15252564pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15252564pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15252564pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15252564pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15252564pubmed:statusMEDLINElld:pubmed
pubmed-article:15252564pubmed:monthJunlld:pubmed
pubmed-article:15252564pubmed:issn1477-9226lld:pubmed
pubmed-article:15252564pubmed:authorpubmed-author:StevensRobert...lld:pubmed
pubmed-article:15252564pubmed:authorpubmed-author:Spasojevi?Iva...lld:pubmed
pubmed-article:15252564pubmed:authorpubmed-author:Batini?-Haber...lld:pubmed
pubmed-article:15252564pubmed:authorpubmed-author:FridovichIrwi...lld:pubmed
pubmed-article:15252564pubmed:authorpubmed-author:Okado-Matsumo...lld:pubmed
pubmed-article:15252564pubmed:authorpubmed-author:NetaPedatsurPlld:pubmed
pubmed-article:15252564pubmed:authorpubmed-author:HambrightPete...lld:pubmed
pubmed-article:15252564pubmed:issnTypePrintlld:pubmed
pubmed-article:15252564pubmed:day7lld:pubmed
pubmed-article:15252564pubmed:ownerNLMlld:pubmed
pubmed-article:15252564pubmed:authorsCompleteYlld:pubmed
pubmed-article:15252564pubmed:pagination1696-702lld:pubmed
pubmed-article:15252564pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:15252564pubmed:meshHeadingpubmed-meshheading:15252564...lld:pubmed
pubmed-article:15252564pubmed:meshHeadingpubmed-meshheading:15252564...lld:pubmed
pubmed-article:15252564pubmed:meshHeadingpubmed-meshheading:15252564...lld:pubmed
pubmed-article:15252564pubmed:meshHeadingpubmed-meshheading:15252564...lld:pubmed
pubmed-article:15252564pubmed:meshHeadingpubmed-meshheading:15252564...lld:pubmed
pubmed-article:15252564pubmed:meshHeadingpubmed-meshheading:15252564...lld:pubmed
pubmed-article:15252564pubmed:meshHeadingpubmed-meshheading:15252564...lld:pubmed
pubmed-article:15252564pubmed:meshHeadingpubmed-meshheading:15252564...lld:pubmed
pubmed-article:15252564pubmed:meshHeadingpubmed-meshheading:15252564...lld:pubmed
pubmed-article:15252564pubmed:meshHeadingpubmed-meshheading:15252564...lld:pubmed
pubmed-article:15252564pubmed:meshHeadingpubmed-meshheading:15252564...lld:pubmed
pubmed-article:15252564pubmed:meshHeadingpubmed-meshheading:15252564...lld:pubmed
pubmed-article:15252564pubmed:year2004lld:pubmed
pubmed-article:15252564pubmed:articleTitleNew class of potent catalysts of O2.-dismutation. Mn(III) ortho-methoxyethylpyridyl- and di-ortho-methoxyethylimidazolylporphyrins.lld:pubmed
pubmed-article:15252564pubmed:affiliationDepartment of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA. ibatinic@duke.edulld:pubmed
pubmed-article:15252564pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15252564pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:15252564pubmed:publicationTypeResearch Support, U.S. Gov't, Non-P.H.S.lld:pubmed
pubmed-article:15252564pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:948403entrezgene:pubmedpubmed-article:15252564lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15252564lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15252564lld:pubmed